Eureka Therapeutics, Inc.

Biotechnology company · Emeryville, California, United States

Eureka Therapeutics, Inc. is a biotechnology company headquartered in Emeryville, California, United States. It has reported private securities offerings to the US SEC, most recently $45 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Eureka Therapeutics at a glance

Typebiotechnology company
HeadquartersEmeryville, California, United States
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1386560

What does Eureka Therapeutics do?

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $45 million sold (2020).

Frequently asked questions about Eureka Therapeutics

Where is Eureka Therapeutics headquartered?

Eureka Therapeutics, Inc. is headquartered in Emeryville, California, United States.

What does Eureka Therapeutics do?

Eureka Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences